Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Selenium is an essential trace element and mineral required in small amounts for human health. It is not synthesized by the body and must be obtained from dietary sources such as Brazil nuts, seafoods, meats, grains and dairy products. Medically and nutritionally classified as a mineral supplement or trace element therapy rather than a pharmaceutical drug per se. Selenium acts primarily as a cofactor for selenoproteins including glutathione peroxidase (an antioxidant enzyme that protects cells from oxidative damage), iodothyronine deiodinases (enzymes involved in thyroid hormone metabolism), and thioredoxin reductase (important for DNA synthesis). Its main mechanism of action is through its role in antioxidant defense systems—neutralizing reactive oxygen species—and supporting immune function. Clinically it is used to treat or prevent selenium deficiency; it has also been studied or used off-label for conditions such as Hashimoto's thyroiditis and high cholesterol. Excessive intake can lead to toxicity with symptoms like hair loss and neurological effects. It is available over-the-counter in oral forms (tablets/capsules) or intravenously when oral administration isn't possible.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on selenium.